Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Immunic Inc.

Immunic Inc. reported $4K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Dynavax Technologies DVAX:US USD 128K 0
Immunic Inc. VTL:US USD 4K 0
Insmed INSM:US USD 1.36M 7K
Intercept Pharmaceuticals ICPT:US USD 42K 0
Mirati Therapeutics MRTX:US USD 58K 0
OraSure Technologies OSUR:US USD 0 0
Regulus Therapeutics RGLS:US USD 17K 0
Revance Therapeutics RVNC:US USD 84K 2K
Ultragenyx Pharmaceutical RARE:US USD 71K 1000
United Therapeutics UTHR:US USD 700K 0